Literature DB >> 11395403

Histone acetyltransferases.

S Y Roth1, J M Denu, C D Allis.   

Abstract

Transcriptional regulation in eukaryotes occurs within a chromatin setting and is strongly influenced by nucleosomal barriers imposed by histone proteins. Among the well-known covalent modifications of histones, the reversible acetylation of internal lysine residues in histone amino-terminal domains has long been positively linked to transcriptional activation. Recent biochemical and genetic studies have identified several large, multisubunit enzyme complexes responsible for bringing about the targeted acetylation of histones and other factors. This review discusses our current understanding of histone acetyltransferases (HATs) or acetyltransferases (ATs): their discovery, substrate specificity, catalytic mechanism, regulation, and functional links to transcription, as well as to other chromatin-modifying activities. Recent studies underscore unexpected connections to both cellular regulatory processes underlying normal development and differentiation, as well as abnormal processes that lead to oncogenesis. Although the functions of HATs and the mechanisms by which they are regulated are only beginning to be understood, these fundamental processes are likely to have far-reaching implications for human biology and disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395403     DOI: 10.1146/annurev.biochem.70.1.81

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  663 in total

1.  Reconstitution of enhancer function in paternal pronuclei of one-cell mouse embryos.

Authors:  L Rastelli; K Robinson; Y Xu; S Majumder
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Addressing protein localization within the nucleus.

Authors:  Wendy A Bickmore; Heidi G E Sutherland
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

3.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

Review 4.  Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

Authors:  Anton Eberharter; Peter B Becker
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

5.  Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation.

Authors:  Kenichi Nishioka; Sergei Chuikov; Kavitha Sarma; Hediye Erdjument-Bromage; C David Allis; Paul Tempst; Danny Reinberg
Journal:  Genes Dev       Date:  2002-02-15       Impact factor: 11.361

6.  Reconstitution of recombinant chromatin establishes a requirement for histone-tail modifications during chromatin assembly and transcription.

Authors:  A Loyola; G LeRoy; Y H Wang; D Reinberg
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

7.  SAGA is an essential in vivo target of the yeast acidic activator Gal4p.

Authors:  S R Bhaumik; M R Green
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

8.  Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1.

Authors:  Ho-Geun Yoon; Doug W Chan; Zhi-Qing Huang; Jiwen Li; Joseph D Fondell; Jun Qin; Jiemin Wong
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

9.  The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation.

Authors:  Zhong Deng; Chi-Ju Chen; Michaela Chamberlin; Fang Lu; Gerd A Blobel; David Speicher; Lisa Ann Cirillo; Kenneth S Zaret; Paul M Lieberman
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

10.  SWI/SNF-dependent chromatin remodeling of RNR3 requires TAF(II)s and the general transcription machinery.

Authors:  Vishva Mitra Sharma; Bing Li; Joseph C Reese
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.